OFIX

Orthofix Medical Inc

OFIX, USA

Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

https://orthofix.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
OFIX
stock
OFIX

How (OFIX) Movements Inform Risk Allocation Models news.stocktradersdaily.com

Read more →
OFIX
stock
OFIX

Geode Capital Management LLC Buys 64,788 Shares of Orthofix Medical Inc. $OFIX Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$22.8

Analyst Picks

Strong Buy

2

Buy

1

Hold

2

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.39

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-5.15 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.74 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

1.21 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

0.88

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 90.43% of the total shares of Orthofix Medical Inc

1.

Engine Capital Management LP

(10.7653%)

since

2025/06/30

2.

Rubric Capital Management LP

(9.4234%)

since

2025/06/30

3.

Paradigm Capital Management, Inc.

(8.4584%)

since

2025/06/30

4.

BlackRock Inc

(8.1317%)

since

2025/06/30

5.

Armistice Capital, LLC

(7.5403%)

since

2025/06/30

6.

Juniper Investment Co, LLC

(6.2524%)

since

2025/06/30

7.

Vanguard Group Inc

(5.9306%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(2.9333%)

since

2025/07/31

9.

Dimensional Fund Advisors, Inc.

(2.7193%)

since

2025/06/30

10.

iShares Russell 2000 ETF

(2.4062%)

since

2025/08/31

11.

State Street Corp

(2.3985%)

since

2025/06/30

12.

Geode Capital Management, LLC

(2.3554%)

since

2025/06/30

13.

Philosophy Capital Management LLC

(2.1403%)

since

2025/06/30

14.

Millennium Management LLC

(2.0025%)

since

2025/06/30

15.

Bank of America Corp

(1.7405%)

since

2025/06/30

16.

Renaissance Technologies Corp

(1.188%)

since

2025/06/30

17.

Paradigm Micro-Cap

(1.1141%)

since

2025/08/31

18.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0722%)

since

2025/07/31

19.

Fidelity Small Cap Index

(0.9742%)

since

2025/06/30

20.

Northern Trust Corp

(0.9299%)

since

2025/06/30

21.

iShares Russell 2000 Value ETF

(0.8722%)

since

2025/08/31

22.

DFA US Targeted Value I

(0.7423%)

since

2025/07/31

23.

Charles Schwab Investment Management Inc

(0.7117%)

since

2025/06/30

24.

Jacobs Levy Equity Management, Inc.

(0.6861%)

since

2025/06/30

25.

Soleus Capital Management, L.P.

(0.6612%)

since

2025/06/30

26.

Gabelli Funds LLC

(0.651%)

since

2025/06/30

27.

Morgan Stanley - Brokerage Accounts

(0.6335%)

since

2025/06/30

28.

Fidelity Extended Market Index

(0.5383%)

since

2025/07/31

29.

Dimensional US Targeted Value ETF

(0.5285%)

since

2025/08/29

30.

iShares US Medical Devices ETF

(0.4953%)

since

2025/08/31

31.

Vanguard Russell 2000 ETF

(0.4688%)

since

2025/07/31

32.

Schwab US Small-Cap ETFâ„¢

(0.4649%)

since

2025/08/30

33.

1290 VT GAMCO Small Company Value IB

(0.3925%)

since

2025/07/31

34.

MoA Small Cap Value Fund

(0.3822%)

since

2025/03/31

35.

Gabelli Small Cap Growth AAA

(0.3573%)

since

2025/06/30

36.

State St Russell Sm Cap® Indx SL Cl I

(0.3015%)

since

2025/08/31

37.

DFA US Small Cap I

(0.2885%)

since

2025/07/31

38.

Keeley Small Cap Fund AAA

(0.2639%)

since

2025/06/30

39.

Dimensional US Small Cap ETF

(0.2599%)

since

2025/08/29

40.

Vanguard Health Care ETF

(0.2553%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.1976

EPS Estimate

-0.3315

EPS Difference

0.5291

Surprise Percent

159.6078%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(4)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.